跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,245 条关于
“Idorsia Ltd.”
全部
9,245
临床试验
1,724
药物
1,498
机构
4,087
资讯
1,936
去年
Nxera Pharma Partners with Shionogi for Quviviq Distribution in Japan Following Approval for Insomnia
2年前
Viatris Expands Pipeline with Idorsia Collaboration, Focuses on Cardiovascular and Autoimmune Therapies
去年
Idorsia's QUVIVIQ Receives Approval in China for Insomnia Treatment Through Simcere Partnership
6个月前
Idorsia Expands QUVIVIQ Access to Gulf States Through Pharmalink Partnership
去年
Idorsia Launches IMPACT-HTN Initiative with Stanford and Duke to Transform Difficult-to-Control Hypertension Care
去年
FDA Removes REMS Requirement for TRYVIO, Simplifying Access to Novel Hypertension Treatment
9个月前
Idorsia's Dual Orexin Receptor Antagonist Wins Inaugural Prix Galien Bridges Award for Insomnia Treatment Innovation
去年
Aprocitentan Shows Significant Blood Pressure and Proteinuria Reduction in Black Patients with Resistant Hypertension
去年
Landmark Cardiology Advancements: Novel Therapies and Key Trial Results in 2024
去年
FDA Approves Tryvio (aprocitentan) for Hypertension Treatment in Combination with Other Antihypertensives
第 1 页,共 194 页
上一页
下一页